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Abstract
Background: Nucleic acid amplification assays including PCR have revolutionized the detection of Mycobacterium
tuberculosis (MTB). Tuberculosis spread to almost every organ of the body and is characterized on the basis of
localization of infection. Therefore, different types of body fluids and tissues can be used for the detection of MTB.
From 2004 to 2010 total 766 different types of smear negative samples from patients, clinically suspected for
tuberculosis were received and investigated at Division of Molecular Diagnostics, University of the Punjab Lahore
for the diagnosis of tuberculosis. Mycobacterial DNA was extracted followed by PCR amplification.
Findings: A total of 356 (46.5%) samples were found positive by PCR for MTB. These included; serum (4.8%), blood
(36.3%), urine (46.6%), cerebro spinal fluid (CSF) (42.1%), ascetic fluid (67.6%), pleural fluid (52%), pericardial fluid
(30%), pus (38.6%), bone marrow (60%), sputum (38.8%) and bronchoalveolar lavage (BAL) (70%). Over all there was
no significant difference in males and females neither in different age groups for the identification of MTB.
Conclusion: We conclude that PCR is a useful and sensitive tool for the early diagnosis of MTB in variety of clinical
samples.
Background
Tuberculosis (TB) is one of the leading chronic infec-
tious bacterial with a death toll of almost 3 million and
more than 8 million new cases each year [1]. It is also
an established fact that 95% of TB cases occur in under-
developed countries [2] including Pakistan where
2,68,000 new cases and 64,000 deaths take place each
year [3]. TB is caused by various species of mycobacteria
among which Mycobacterium tuberculosis (MTB) is the
most frequent [4] that is a slow growing facultative
intracellular parasite [5].
Generally tuberculosis is diagnosed by conventional
methods like sputum smear microscopy, chest radio-
graphic findings and culture studies [6]. The existing
methodologies remain ineffective due to limitations due
to low mycobacterium levels and/or time consuming
procedures [7]. Accurate and early diagnosis of TB is
important for effective management and timely
treatment. At present nucleic acid amplification based
assays are the most suitable choice for the identification
of MTB that has eliminated diagnostic problems with
improved detection rates in smear negative samples
with high degree of sensitivity and specificity [6-9] in
both pulmonary and extra-pulmonary cases. Pulmonary
and extra pulmonary TB types are different on the basis
of location of the infection which could be inside or
outside lungs respectively [10]. Pulmonary disease is
believed to be more common but extra-pulmonary
remains quite severe because of unapparent and nonspe-
cific outcome [11].
The current study was designed to determine the clin-
ical utility of MTB PCR test for the rapid diagnosis of
both extra-pulmonary and pulmonary TB in a variety of
clinical samples from Pakistan targeting the MTB-speci-
fic Insertion sequence 986/6110 (IS986/IS6110) that is
present in multiple copies in MTB complex. It is well-
known that TB spread to different organs and locations
within the body such as brain, bones, abdomen, heart,
lymphatic system, urinary tract and lungs. Therefore, we
used blood, serum, CSF, Ascetic fluid, Urine, Sputum,
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fluid, Pus and Bone marrow as specimens for MTB
detection through PCR method.
Methods
Patient’s samples
Total 766 specimens from patients with a high clinical
suspicion of pulmonary or extra-pulmonary tuberculosis
were received at Division of Molecular Diagnostics
CEMB, University of the Punjab from July 2004 to
October 2010 for the detection of MTB including
Serum (n = 41), Blood (n = 88), Urine (n = 225), Cere-
bro Spinal Fluid (CSF) (n = 76), Ascitic Fluid (n = 133),
Pleural Fluid (n = 98), Pericardial Fluid (n = 10), pus (n
=4 4 ) ,B o n eM a r r o w( n=5 ) ,S p u t u m( n=3 6 )a n d
Bronchoalveolar Lavage (BAL) (n = 10). All these sam-
ples were smearing negative. Pulmonary tuberculosis
was defined as tuberculosis of lungs, pleura, and med-
iastinal lymph nodes whereas extra-pulmonary TB is
disease outside these sites. In Pakistan tuberculosis is
highly endemic. Several TB clinics and surveillance cen-
ters in Pakistan offer free diagnostic facility mostly
based on smear examination will all the limitation of
low sensitivities. None of these Centers has the modern
molecular techniques for the diagnosis of TB. Ethical
approval was not needed for the current study as all the
samples from the subjects were received for clinical
diagnosis from tertiary collection points and we had not
disclosed any identification of the subjects.
Sample processing and Heat inactivation
Immediately receiving, the samples were incubated at 80
C for 10 minutes to kill MTB. The sputum samples
were digested and decontaminated with NALC-NaOH
method. All the samples were concentrated by centrifu-
gation at 5000 × g for 5 minutes. The pellet was used
for DNA extraction.
DNA Extraction
Total DNA was extracted from samples using commer-
cially available kit (Gentra Purescrift, USA) according to
the procedure given in the kit protocol for each type of
sample. The DNA pellet was reconstituted in 20 ul dis-
tilled water and stored at minus 20°C if not used that
time for PCR amplification.
PCR Amplification
PCR amplification was performed as previously
described by Eisenach and colleagues [12]. The assay
detects a 123-bp region from the M. tuberculosis com-
plex-specific insertion sequence IS6110. Briefly, PCR
amplification was performed for the detection of TB
using forward primer (5’-CCT GCG AGC GTA GGC
GTC GGT-3’) and reverse primer (5’-CTC CTC CAG
CCC CCC CTT CCC-3’). The PCR reactions were per-
formed in a final volume of 25 micro letter contained
10 mM Tris-HCl (pH 8.3), 50 mM KCl, 2.5 mM MgCl2,
0.01% gelatin, 0.2 mM (each) de-oxynucleoside tripho-
sphate, 1 mM each of forward and reverse primers and
1 U of Taq DNA polymerase Enzyme (Gibco BRL Life
Technologies USA). The thermalcycler (Applied Biosys-
tem Inc., PCR system 2700) was programmed to initially
incubate the samples for 2 min at 94°C, followed by 35
cycles consisting of 94°C for 45 seconds, 53°C for 45
seconds and 72°C for 1 minute. Final extension was
given at 72°C for 10 minutes. Specific TB DNA detec-
tion for each sample was identified by specific 123-bp
DNA bands on 2% agarose gel, stained with ethidium
bromide, and evaluated under UV transilluminator. The
estimation of the sizes of PCR products was done
according to the migration pattern of a 100-bp DNA
ladder (Gibco BRL Life Technologies USA).
To avoid cross-contamination between samples and
contamination of reagents or samples with PCR-ampli-
fied products or positive controls all the procedures for
sample preparation and PCR included measures were
observed as described by Kwok and Higuchi [13]. DNA
extraction, preparation of reaction mixture and PCR
amplification were carried out in three separate labora-
tory rooms located far away from each other.
In all steps filtered tips were used to avoid carry over
contamination. All the samples were run in duplicate.
Statistical analysis
Statistical analysis was done using SPSS program for
window. Statistical significance for comparisons of pro-
portions was determined by the Fisher exact test.
Results
In the current study, smear negative TB samples of total
766 clinically suspected tuberculosis patients were ana-
lyzed for mycobacterial DNA detection in different types
of samples. Of these 437 (57.04%) were from male
patients and 329 (42.95%) were from female patients.
The mean (± SD) age was 45 ± 17 ranged from 5 years
to 79 years Ninety four percent of the cases had sus-
pected Extra-pulmonary TB and 6% were suspected for
pulmonary TB. Of the 766 cases, 356 (46.5%) were
found positive for TB by PCR method. Different types
of respiratory and non respiratory samples showed dif-
ferent positivity rates as described in Table 1. It is
observed that 70% of the BAL samples were found TB
positive followed by 67.6% TB positive CSF samples
while pericardial TB samples were least positive (30%).
Table 2 translates the positive mycobacterial DNA in
different types of samples in males and females. Overall
there was no significant difference of TB positivity in
males (46.4%) and females (46.5%). Males showed higher
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pus and BAL samples while females showed higher rates
in urine, CSF, Pleural fluid, bone marrow and sputum
samples. The positivity was seen significantly high (p <
0.05) in females compared to males in urine samples.
?tlsb=-0.015w?>Effect of age on samples positivity was
also being evaluated. It was found that most of the posi-
tive samples lie in the age group of 41 to 60 years (35.6%)
while 34.2% samples were positive in the age group of
21-40 years (Table 3).
Discussion
Tuberculosis (TB) kills more people in Southeast Asia
including Pakistan than any other infectious disease.
According to World Health Organization (WHO)
reports [1,14] Pakistan is among the 22 countries having
a high incidence of TB where an increase in the rate of
MDR-TB and XDR TB strains has been reported in this
region of the world [15]. The main reason for this
depressing situation is the unavailability of rapid, more
sensitive and specific techniques for the timely diagnosis
of TB. The early and accurate identification of MTB
facilitates control, prevention and treatment of this
chronic disease. In addition TB detection and treatment
are also difficult in underdeveloped countries, like Paki-
stan, that are facing multifaceted emergencies, including
humanitarian crises and conflicts [14]. Accurate and
timely diagnosis is crucial for timely treatment that
might minimize the risk of disease transmission. Several
techniques are available for the diagnosis of TB such as
smear examination, culturing, ELISA based and PCR-
based detection methods. Among these culturing of the
M. tuberculosis remains the gold standard method for
diagnosing TB however it is time consuming and takes
5-6 weeks. Direct smear examination under microscope
is the most popular among all the methods currently
employed worldwide for TB diagnosis as it is very rapid
but has the issues of low sensitivities and low specifici-
ties. In view of the huge convenience of smear micro-
scopy, frequent efforts have been made to improve its
sensitivity and specificity [16-18], however, the smear
examination method still has the sensitivity problem as
direct smear microscopy lacks sensitivity and versatility
in terms of application to extra-pulmonary specimens.
After the discovery of polymerase chain reaction (PCR)
technique, maximum attention has been given to devel-
oping nucleic acid based amplification diagnostic techni-
ques due to its speed, specificity and sensitivity. Several
TB gene targets based on automated and semi-auto-
mated kits for mycobacterial DNA detection are avail-
able and are being extensively evaluated [19-22].
In the current study we studied the clinical utility of
MTB PCR test for the rapid diagnosis of both extra-pul-
monary and pulmonary tuberculosis with higher
Table 1 Positivity rates of MTB in different types of










1 Serum 41 2 4.8%
2 Blood 88 32 36.3%
3 Urine 225 105 46.6%
4 CSF 76 32 42.1%
5 Ascitic Fluid 133 90 67.6%




8 Pus 44 17 38.6%
9 Bone Marrow 5 3 60%
10 Sputum 36 14 38.8%
11 BAL 10 7 70%
12 Total 766 356 46.4%
MTB: Mycobacterium tuberculosis; CSF: cerebro spinal fluid; BAL:
bronchoalveolar lavage;
Table 2 Positivity rates of MTB in males and females (n = 766)
Sr.No. Type of Sample Total Samples Received Males Positive/Total (%age) Female Positive/Total (%age) p-value
1 Serum 41 0/27 2/14 (14.2%) 0.1
2 Blood 88 18/41 (43.9%) 14/47 (29.7%) 0.2
3 Urine 225 53/134 (39.5%) 52/91 (57.1%) 0.07
4 CSF 76 16/41 (39%) 16/35 (45.7%) 0.1
5 Ascitic Fluid 133 61/81 (75%) 29/52 (55.7%) 0.1
6 Pleural Fluid 98 30/58 (51.7%) 21/40 (52.5%) 0.5
7 Pericardial Fluid 10 3/9 (33.3%) 0/1 0.7
8 Pus 44 11/25 (44%) 6/19 (31.5%) 0.39
9 Bone Marrow 5 1/2 (50%) 2/3 (66.6%) 0.5
10 Sputum 36 5/13 (38.4%) 9/23 (39.1%) 0.2
11 BAL 10 5/6 (83.3%) 2/4 (50%) 0.5
12 Total 766 203/437 (46.4%) 153/329 (46.5%) NS
MTB: Mycobacterium tuberculosis; CSF: cerebro spinal fluid; BAL: bronchoalveolar lavage; NS: Non-significant
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blood, serum/plasma, CSF, Ascetic fluid, Urine, Sputum,
Bronchoalveolar Lavage (BAL), Pleural fluid, Pericardial
fluid, Pus and Bone marrow. We were able to detect TB
DNA in 46.5% (356/766) smear negative TB samples by
PCR amplification method. It has previously been esti-
mated that the sensitivity and specificity rates for M.
tuberculosis culture that is a reference standard are
approximately 96% and 81%, however their significant
variability in different studies limits their value for clini-
cal diagnostic purposes [23]. For example most recently
the reported positivity rate of TB is just 15%-20% in
Pakistan using culturing on a very large number of
(more than 50,000) specimen received from different
geographical areas of the country [24] that is very low.
The positivity rates were different in different types of
pulmonary and extra-pulmonary TB samples. It was
observed that 70% of the BAL samples were found TB
positive followed by 67.6% TB positive CSF samples
though all these were smear negative. In pericardial TB
samples the positivity rate was 30%. Additionally this
method can detect TB with same high sensitivity in
males and females as no significant difference of TB
positivity in males (46.4%) and females (46.5%) were
seen. Regarding positivity rates in different specimens,
among males, higher positivity rates were observed in
blood, ascetic fluid, pericardial fluid, pus and BAL sam-
ples while females showed higher positivity rates in
urine, CSF, Pleural fluid, bone marrow and sputum sam-
ples. Effect of age on samples positivity was also being
evaluated. It was found that most of the positive sam-
ples lie in the age group of 41 to 60 years (35.6%) while
34.2% samples were positive in the ages between 21
years and 40 years.
With respect to the diagnostic value of PCR in the
evaluation of patients with suspected pulmonary and
extra-pulmonary TB, we observed that, because of its
very high sensitivity with AFB smear negative samples,
the test can be confidently used to accurately diagnose
TB. Patients having TB like symptoms with negative
PCR might be due to opportunistic infectious agents
particularly due to non tuberculos mycobacterium
(NTM). The propensity of both clinical suspicion and
positive TB PCR to overestimate the probability of TB
might lead to mistaken initiation of therapy, isolation,
and contact investigation (23).
Conclusion
We conclude that PCR assay is highly sensitive and spe-
cific tool available to date for the diagnosis of M tuber-
culosis in all types of specimens obtained from patients
with a clinical suspicion of tuberculosis whether pul-
monary or extra-pulmonary and can be reliably used for
rapid identification of TB.
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